title: More transparency for a therapeutic window in platelet P2Y12 inhibition?
authors.affiliation: Department of Cardiovascular Science, University of Sheffield Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK r.f.storey@sheffield.ac.uk.
authors.forename: Robert F
authors.initials: RF
authors.lastname: Storey
mesh_terms: D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008297:Male; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects*; D015539:Platelet Activation / Q000187:drug effects*; D058921:Purinergic P2Y Receptor Antagonists / Q000009:adverse effects*; D015607:Stents; D013927:Thrombosis / Q000139:chemically induced*
chemical_list: D058921:Purinergic P2Y Receptor Antagonists